PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Publisher： Karger

E-ISSN： 1661-3805|11|6|385-390

ISSN： 1661-3791

Source： Breast Care, Vol.11, Iss.6, 2016-12, pp. : 385-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Checkpoint Inhibitors and Their Application in Breast Cancer

By  

Breast Care, Vol. 11, Iss. 2, 2016-04 ,pp. : 108-115

Karger

Access to resources Recommend Favorite

Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy

By  

Breast Care, Vol. 11, Iss. 2, 2016-04 ,pp. : 102-107

Karger

Access to resources Recommend Favorite

Breast Cancer and Immune Thrombocytopenic Purpura: Is there any Association between these 2 Distinct Diseases?

By  

Breast Care, Vol. 2, Iss. 5, 2007-10 ,pp. : 317-320

Karger

Access to resources Recommend Favorite

Breast Cancer Chemoprevention – not yet There

By  

Breast Care, Vol. 1, Iss. 5, 2006-10 ,pp. : 295-296

Karger

Access to resources Recommend Favorite

Dissecting the Heterogeneity of Breast Cancer*

By  

Breast Care, Vol. 2, Iss. 3, 2007-06 ,pp. : 151-156

Karger

Access to resources Recommend Favorite